Evidence map›Paper›PMID 19564475›Full record

ReviewDiabetes care2009

Anemia, diabetes, and chronic kidney disease.

Uzma Mehdi, Robert D Toto

Abstract readReview
In one paragraph

Review in Diabetes care, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Canagliflozin and iron metabolism in the CREDENCE trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025 · on this map
    Trial
  6. Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study.Clinical research in cardiology : official journal of the German Cardiac Society · 2024
    Trial
  7. Trial
  8. Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open-label study in Japan.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2021
    Trial
  9. Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Trial
  10. Trial
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Uzma MehdiDepartment of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Robert D Toto

Funding

MENTORING PROGRAM FOR CLINICAL RESEARCHERS IN NEPHROLOGYK24DK002818 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2001 to 2010
$1.5M
NIDDK NIH HHS 5-K24-DK002818-05NIDDK NIH HHS K24 DK002818
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnemiaAnimalsDiabetic NephropathiesDisease ProgressionEpoetin AlfaErythropoietinFemaleHumansKidney Failure, ChronicMaleNephrotic SyndromeProteinuriaQuality of LifeRandomized Controlled Trials as TopicRecombinant ProteinsEpoetin AlfaErythropoietinRecombinant Proteins

Identifiers

PMID19564475
PMCPMC2699743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.